Latest News and Press Releases
Want to stay updated on the latest news?
-
The trial's objectives are to evaluate the safety, tolerability and efficacy of SciSparc's SCI-210 in children and adolescents with ASD TEL AVIV, Israel, Aug. 08, 2022 (GLOBE NEWSWIRE) -- ...
-
PRESS RELEASE UPDATE ON MAISONS DU MONDE’SSHARE BUYBACK PROGRAM NANTES – 08 August 2022 Maisons du Monde reports share buyback transactions executed during the week of 1 August 2022, under...
-
MÅ IKKE OFFENTLIGGØRES, PUBLICERES ELLER DISTRIBUERES, DIREKTE ELLER INDIREKTE, I ELLER TIL NOGEN JURISDIKTION, HVIS DETTE VILLE UDGØRE EN OVERTRÆDELSE AF GÆLDENDE RET ELLER REGULERING I DEN...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. ...
-
Chicago, IL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Himalaya Technologies, Inc. (OTC: HMLA) is providing a shareholder update on its operating activities, minority investments, and growth plans. The...
-
MÅ IKKE OFFENTLIGGØRES, PUBLICERES ELLER DISTRIBUERES, DIREKTE ELLER INDIREKTE, I ELLER TIL NOGEN JURISDIKTION, HVIS DETTE VILLE UDGØRE EN OVERTRÆDELSE AF GÆLDENDE RET ELLER REGULERING I DEN...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. ...
-
BETHESDA, Md., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug discovery with its proprietary...
-
VANCOUVER, British Columbia, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO, NVO.WT & NVO.WT.A) (OTCQX: NSRPF) is pleased to advise that it has closed...
-
Glen Rock, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...